Scientists have uncovered an unexpected mechanism by which psilocybin, the active compound in magic mushrooms, rapidly reshapes the brain, according to findings that could reframe research into stress-related mental illness. The study reports that the compound spurs the formation of new neural connections and strengthens existing ones within a short window, demonstrating a plasticity-promoting effect that researchers say was not anticipated. Notably, the drug behaved differently in healthy mice compared with chronically stressed animals, suggesting it may help repair brain circuits damaged by prolonged stress exposure.
Perhaps most intriguingly, the team identified a method to trigger this rewiring without producing the behavioral responses typically associated with psychedelic effects, a distinction that could inform future therapeutic development. The discovery adds to a growing body of research examining psilocybin's potential in treating conditions such as depression and anxiety, though the findings derive from animal models and require validation in human trials. Researchers cautioned that the results do not support recreational use and that clinical applications remain years away pending further safety and efficacy studies.
Independent reporting synthesized from primary wires and global correspondents.